
Avibact S 1000mg/500mg Injection
Marketer
Auroswift Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Avibact S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable formulation, combats diverse bacterial infections. Its dual-action mechanism inhibits microbial proliferation, curbing infection spread. Administration must be solely under a physician's guidance; adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are vital for optimal recovery. Your physician may order lab tests to monitor treatment effectiveness.
Uses of Avibact S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Avibact S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Avibact S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Avibact S 1000mg/500mg Injection:
Administering this medication will be done by your healthcare provider; self-medication is strictly prohibited.
How Avibact S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Avibact S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by overcoming bacterial resistance mechanisms, thus maximizing the antibiotic's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Avibact S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation Avibact S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Avibact S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Avibact S 1000mg/500mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Avibact S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive Avibact S 1000mg/500mg Injection cautiously, potentially requiring dosage modification. Medical advice is necessary. Dosage alteration of Avibact S 1000mg/500mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Avibact S 1000mg/500mg Injection :
Omitting a scheduled dose of Avibact S 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Avibact S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Agents against infection |
